Terms: = Sarcomas AND SMAD3, JV15-2, 4088, ENSG00000166949, P84022, Smad3, MADH3, HsT17436, Smad 3, DKFZp686J10186, HSPC193, DKFZP586N0721, MGC60396
40 results:
1. (E)-SIS3 suppressed osteosarcoma progression via promoting cell apoptosis, arresting cell cycle, and regulating the tumor immune microenvironment.
Huang Z; Zhang C; Zhu K; Hu J; Xu E; Ma X; Wang Y; Zhu Y; Zhu J
Drug Dev Res; 2023 Dec; 84(8):1751-1763. PubMed ID: 37784254
[TBL] [Abstract] [Full Text] [Related]
2. Gene fusions in superficial mesenchymal neoplasms: Emerging entities and useful diagnostic adjuncts.
Fischer GM; Papke DJ
Semin Diagn Pathol; 2023 Jul; 40(4):246-257. PubMed ID: 37156707
[TBL] [Abstract] [Full Text] [Related]
3. The mechanism of VCP-mediated metastasis of osteosarcoma based on cell autophagy and the EMT pathway.
Li AA; Zhang Y; Li F; Zhou Y; Liu ZL; Long XH
Clin Transl Oncol; 2023 Mar; 25(3):653-661. PubMed ID: 36284060
[TBL] [Abstract] [Full Text] [Related]
4. New molecular entities of soft tissue and bone tumors.
Lam SW; Silva TM; Bovée JVMG
Curr Opin Oncol; 2022 Jul; 34(4):354-361. PubMed ID: 35730501
[TBL] [Abstract] [Full Text] [Related]
5. Recent advances in the diagnosis, classification and molecular pathogenesis of cutaneous mesenchymal neoplasms.
Papke DJ; Hornick JL
Histopathology; 2022 Jan; 80(1):216-232. PubMed ID: 34958499
[TBL] [Abstract] [Full Text] [Related]
6. [MiR-671-5p negatively regulates smad3 to inhibit migration and invasion of osteosarcoma cells].
Hu Y; Liang D; Chen X; Chen L; Bai J; Li H; Yin C; Zhong W
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Oct; 41(10):1562-1568. PubMed ID: 34755673
[TBL] [Abstract] [Full Text] [Related]
7. VGLL3 activates inflammatory responses by inducing interleukin-1α secretion.
Takakura Y; Hori N; Terada N; Machida M; Yamaguchi N; Takano H; Yamaguchi N
FASEB J; 2021 Nov; 35(11):e21996. PubMed ID: 34679187
[TBL] [Abstract] [Full Text] [Related]
8. TGF‑β inhibitor RepSox suppresses osteosarcoma via the JNK/smad3 signaling pathway.
He D; Gao J; Zheng L; Liu S; Ye L; Lai H; Pan B; Pan W; Lou C; Chen Z; Fan S
Int J Oncol; 2021 Nov; 59(5):. PubMed ID: 34533199
[TBL] [Abstract] [Full Text] [Related]
9. Update on Cutaneous Soft Tissue Tumors.
Dermawan JK; Ko JS; Billings SD
Surg Pathol Clin; 2021 Jun; 14(2):195-207. PubMed ID: 34023100
[TBL] [Abstract] [Full Text] [Related]
10. EWSR1-smad3 fibroblastic tumour of bone: expanding the clinical spectrum.
De Noon S; Flanagan AM; Tirabosco R; O'Donnell P; Amary F
Skeletal Radiol; 2021 Feb; 50(2):445-450. PubMed ID: 32710151
[TBL] [Abstract] [Full Text] [Related]
11.
Foot O; Hallin M; Jones RL; Sumathi VP; Thway K
Int J Surg Pathol; 2021 Apr; 29(2):179-181. PubMed ID: 32615834
[No Abstract] [Full Text] [Related]
12. MicroRNA-330-5p promotes the development of osteosarcoma by regulating SPRY2.
Wei Q; Li QQ; Zhai XC; Qin L; Li HB; Meng R; Han XF
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8761-8770. PubMed ID: 31696462
[TBL] [Abstract] [Full Text] [Related]
13. GDF15 promotes osteosarcoma cell migration and invasion by regulating the TGF‑β signaling pathway.
Chen G; Wang M; Liu X
Mol Med Rep; 2019 Nov; 20(5):4262-4270. PubMed ID: 31545486
[TBL] [Abstract] [Full Text] [Related]
14. Overexpression of ERβ inhibits the proliferation through regulating TNG-β signaling pathway in osteosarcoma.
Zhang Y; Zhou X; Yin C; Wu Y; Wang L
Pathol Res Pract; 2019 Oct; 215(10):152568. PubMed ID: 31383536
[TBL] [Abstract] [Full Text] [Related]
15. Chromatin remodeling factor BAZ1A regulates cellular senescence in both cancer and normal cells.
Li X; Ding D; Yao J; Zhou B; Shen T; Qi Y; Ni T; Wei G
Life Sci; 2019 Jul; 229():225-232. PubMed ID: 31085244
[TBL] [Abstract] [Full Text] [Related]
16. MicroRNA-1269a promotes the occurrence and progression of osteosarcoma by inhibit-ing TGF-β1 expression.
Yu SN; Miao YY; Zhang BT; Dai YM; Liu L; Gao ZL; Liu GF
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):972-981. PubMed ID: 30779063
[TBL] [Abstract] [Full Text] [Related]
17. Growth rate and myofibroblast differentiation of desmoid fibroblast-like cells are modulated by TGF-β signaling.
Enzo MV; Cattelan P; Rastrelli M; Tosi A; Rossi CR; Hladnik U; Segat D
Histochem Cell Biol; 2019 Feb; 151(2):145-160. PubMed ID: 30173360
[TBL] [Abstract] [Full Text] [Related]
18. Platelet-Derived TGF-β Induces Tissue Factor Expression via the smad3 Pathway in Osteosarcoma Cells.
Saito M; Ichikawa J; Ando T; Schoenecker JG; Ohba T; Koyama K; Suzuki-Inoue K; Haro H
J Bone Miner Res; 2018 Nov; 33(11):2048-2058. PubMed ID: 29949655
[TBL] [Abstract] [Full Text] [Related]
19. ING5 is a Potential Target for Osteosarcoma Therapy.
Zhang X; Xu ZH; Xie H; Sun YW; Liu J; Zhao YB
Technol Cancer Res Treat; 2018 Jan; 17():1533033818762680. PubMed ID: 29528777
[TBL] [Abstract] [Full Text] [Related]
20. TGF-β signalling and PEG10 are mutually exclusive and inhibitory in chondrosarcoma cells.
Shinohara N; Maeda S; Yahiro Y; Sakuma D; Matsuyama K; Imamura K; Kawamura I; Setoguchi T; Ishidou Y; Nagano S; Komiya S
Sci Rep; 2017 Oct; 7(1):13494. PubMed ID: 29044189
[TBL] [Abstract] [Full Text] [Related]
[Next]
